Log in
The activities of the Organic Materials Innovation Centre (OMIC) at the University of Manchester generate impact from its research activities through knowledge transfer to industry. This is exemplified by:
Provision of research-based training in the field of printed electronics and sensors to over 250 people from 2008 onwards.
This University of Manchester research underpins UK industry's global position in millimetre- wave imaging and ultra-high-precision sensing. These are key technologies in a range of industrial, medical and consumer electronics applications. The devices and methods developed by the research team are now used by a range of companies leading to economic impacts for the UK in strong export markets. In this case study we provide examples of impacts that support commercial sales in excess of £300m by UK SME and FTSE-listed companies in three sectors: automotive radar (e2v), terahertz imaging (TeraView), and linear encoders (Renishaw PLC).
Research at the University of Manchester has led to the provision of cost effective instruments for monitoring water, industrial and environmental pollution. The underpinning research on chemical sensors conducted in the unit was protected by patent, and in 2007 Multisensor Systems Ltd was spun-out in-order to meet the needs of the water industry and has grown to employ 6 people in 2013. Currently this is the only commercially available instrument sensitive enough to monitor low concentrations of hydrocarbon pollution and is used by major UK water companies to prevent risk of environmental pollution hazards with mitigated losses valued at more than £100m.
The need to manage, analyse and interpret the volumes of data and literature generated by modern high-throughput biology has become a major barrier to progress. Research at the University of Manchester on interoperability and advanced interfaces has resulted in innovative software (Utopia Documents) that links biomedical data with scientific literature. The software has been adopted by international publishing houses (Portland Press, Elsevier, Springer, etc.), allowing them to explore new business models, and by pharmaceutical companies (e.g. AstraZeneca, Roche), providing new opportunities to explore more efficient, cost-effective methods for exploiting and sharing in-house data and knowledge. The research also led to a spin-out company, Lost Island Labs, in 2012, which expects a profit [text removed for publication] in its first year.
BRITEST is a global leader in the development of innovative process solutions for the chemical processing sector with > £500m of value being realized since 2008. Research in Manchester (1997-2000) generated a set of novel tools and methodologies which analyse chemical processes to identify where and how process improvements could be made. BRITEST was established in 2001 as a not-for-profit company to manage the technology transfer and effective deployment of these tools and methodologies into industry. Manchester holds the IP arising from the underpinning research and has granted an exclusive license to BRITEST for use and exploitation of the toolkit.
The lasting impact of Professor Prag's work on facial reconstruction is that it has become a vital tool for archaeologists, helping them to understand the past better. Facial reconstruction now plays a major role in many museum exhibitions around the world and the techniques developed in Manchester have increased public interest in past civilizations. An important aspect in the reconstruction process is the ability to work across disciplines to produce a complete picture. Manchester has pioneered this method of collaborative working with some ground-breaking results. The facial recognition methods established by Professor Prag continue to impact on archaeological and museum practices around the world to bring history truly to life.
The impact presented in this case study is the commercialisation of 15 products with perfume microcapsules by Procter and Gamble (P&G), made possible using capsule mechanical strength data provided by Prof Zhibing Zhang's research group at Birmingham. Use of microcapsules gives improved freshness performance, and thus commercial advantage, compared with traditional formulations; they have been incorporated in P&G's four major billion-dollar brands — Downy, Febreze, Lenor and Tide. This has significantly improved their competitiveness enabling P&G to retain their leading position in the USA and Western Europe. A novel micromanipulation technique developed at the University of Birmingham has been used extensively to obtain mechanical properties data for the micro-particles, including microcapsules prepared in Birmingham and provided by companies, which is related to their formulation and processing conditions and end- use performance. In addition, the knowledge generated has helped 15 other companies to commercialise new functional products containing micro-particles.
RTT (Real Time Tomography) scanning systems for airport baggage are becoming increasingly important due to growing air traffic and greater security concerns. Prior to our research, Rapiscan, a leading producer of baggage scanners, had been unable to make full use of the hardware in their latest generation of scanner prototypes. Our novel theory and image reconstruction algorithms are now a core part of a commercially successful 3D scanner that is significantly faster and more accurate than previous generations. The two models, RTT80 and large RTT110, have been approved by regulatory authorities and have already been field trialled at Manchester Airport and deployed at Seattle airport, with further US$20m orders placed.
The research and impact described herein was flagged in the citation for the UoM's 2013 Queen's Anniversary Prize for Higher and Further Education for its work in imaging techniques to support advanced materials and manufacturing.
Pioneering research in the UoA has driven significant advances in diffusion-ordered nuclear magnetic resonance spectroscopy (DOSY), resulting in pulse sequence and analysis software that has been commercialised under licence by Agilent, and distributed as open-source software across 68 countries. DOSY has given a manufacturer of NMR equipment a competitive advantage that has contributed to several $10m's of instrument sales since 2009. These advances have changed practice and capacity in industry, through the introduction of new products and processes: one of the world's largest chemical companies is using the technique in about 30 % of all formulation projects. DOSY is having significant economic impact: one food industry company reporting sales growth of £35m in the REF period as a direct result of the use of DOSY.
Research at Manchester has led to the development of a new class of high performance magnesium alloys based on the addition of rare-earth alloying elements. The new alloys combine low density and the highest strength of any magnesium alloy. Used to substitute for aluminium in aerospace and automotive they produce weight savings of 35% improving performance and reducing fuel consumption. Commercialisation of these alloys by Magnesium Elektron (ME), the international leader in magnesium alloy development, contributes over $20m per annum to company revenue. This includes development of the first commercial product available for bioresorbable magnesium implants, SynermagTM, launched in 2012.